169 related articles for article (PubMed ID: 8059539)
21. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
[TBL] [Abstract][Full Text] [Related]
22. Distribution to the skin of penciclovir after oral famciclovir administration in healthy volunteers: comparison of the suction blister technique and cutaneous microdialysis.
Borg N; Götharson E; Benfeldt E; Groth L; Ståhle L
Acta Derm Venereol; 1999 Jul; 79(4):274-7. PubMed ID: 10429982
[TBL] [Abstract][Full Text] [Related]
23. In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites.
Groth AD; Contreras MT; Kado-Fong HK; Nguyen KQ; Thomasy SM; Maggs DJ
Vet Ophthalmol; 2014 Jul; 17(4):268-74. PubMed ID: 24112415
[TBL] [Abstract][Full Text] [Related]
24. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
25. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
26. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study.
Tiseo PJ; Perdomo CA; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761
[TBL] [Abstract][Full Text] [Related]
28. Disposition and biotransformation of the acetylenic retinoid tazarotene in humans.
Attar M; Yu D; Ni J; Yu Z; Ling KH; Tang-Liu DD
J Pharm Sci; 2005 Oct; 94(10):2246-55. PubMed ID: 16136553
[TBL] [Abstract][Full Text] [Related]
29. Penciclovir pharmacokinetics after oral and rectal administration of famciclovir in African elephants (Loxodonta africana) shows that effective concentrations can be achieved from rectal administration, despite lower absorption.
Griffioen JA; Fayette MA; Proudfoot JS; Howard LL; Papich MG
Am J Vet Res; 2024 Jul; 85(7):. PubMed ID: 38684186
[TBL] [Abstract][Full Text] [Related]
30. Population pharmacokinetics and optimal design of paediatric studies for famciclovir.
Ogungbenro K; Matthews I; Looby M; Kaiser G; Graham G; Aarons L
Br J Clin Pharmacol; 2009 Oct; 68(4):546-60. PubMed ID: 19843058
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the absorption, metabolism and excretion of [¹⁴C]pasireotide in healthy volunteers using accelerator mass spectrometry.
Lin TH; Hu K; Flarakos J; Sharr-McMahon M; Mangold JB; He H; Wang Y
Cancer Chemother Pharmacol; 2013 Jul; 72(1):181-8. PubMed ID: 23680921
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.
Midgley I; Chasseaud LF; Taylor IW; Walmsley LM; Fowkes AG; Darragh A; Lambe RF; Bonn R
Xenobiotica; 1985 Nov; 15(11):965-77. PubMed ID: 4082636
[TBL] [Abstract][Full Text] [Related]
34. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.
Webber C; Roth A; Persiani S; Peard AJ; Makovec F; Kapil RP; John BA; Holding JD; D'amato M; Cybulski ZR; Chasseaud LF; Rovati LC
Xenobiotica; 2003 Jun; 33(6):625-41. PubMed ID: 12851039
[TBL] [Abstract][Full Text] [Related]
37. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
38. Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients.
Clive S; Woo MM; Nydam T; Kelly L; Squier M; Kagan M
Cancer Chemother Pharmacol; 2012 Oct; 70(4):513-22. PubMed ID: 22864948
[TBL] [Abstract][Full Text] [Related]
39. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
40. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
